Evidence map›Paper›PMID 30196051›Full record

ArticleNeurobiology of disease2019

Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging.

Svetlana M Stamatovic, Gabriela Martinez-Revollar, Anna Hu, Jennifer Choi, Richard F Keep, Anuska V Andjelkovic

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 2 syntheses or guidelines pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. The blood-brain barrier: a help and a hindrance.Brain : a journal of neurology · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Svetlana M StamatovicDepartment of Pathology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Gabriela Martinez-RevollarDepartment of Pathology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Anna HuDepartment of Pathology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Jennifer ChoiDepartment of Pathology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Richard F KeepDepartment of Neurosurgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA; Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Anuska V AndjelkovicDepartment of Pathology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA; Department of Neurosurgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: anuskaa@med.umich.edu.
University of Michigan–Ann Arbor · US

Funding

Claudin Expression Profiles and Blood Brain Barrier in AgingRF1AG057928 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDJELKOVIC-ZOCHOWSKA, ANUSKA V. · 2017 to 2017
$2.3M
Influence of Brain Inflammation on the Occurrence of Embolic StrokeR21NS098211 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STAMATOVIC, SVETLANA M · 2016 to 2017
$421k
NIA NIH HHS RF1 AG057928NINDS NIH HHS R21 NS098211
6 · The paper itself

Abstract

Accumulating evidence suggest that cerebral microvascular disease increases with advancing age and is associated with lacunar stroke, leukoaraiosis, vascular dementia and Alzheimer disease. Increased blood brain barrier (BBB) permeability/leakage takes "center stage" in ongoing age-related vascular/brain parenchymal injury. Although significant effort has been made in defining the gene mutations and risk factors involved in microvascular alterations in vascular dementia and Alzheimer disease, the intra- and intercellular pathogenic mechanisms responsible for vascular hyperpermeability are still largely unknown. The present study aimed to reveal the ongoing senescence process in brain endothelial cells and its effect on BBB integrity in healthy/non-disease conditions. An analysis of BBB integrity during the life span of C56Bl6 mice (young, 2-6 months; middle-aged, 6-12, months; old, 16-22 months) showed increased BBB permeability for different molecular sized tracers (sodium fluorescein, inulin and 20 kDa dextran) in aged mice which was accompanied by modifications in tight junction (TJ) complex organization, manifested as altered TJ protein expression (particularly claudin-5). A gene screening analysis of aging associated markers in brain microvessels isolated from "aged" mice (C56Bl6, 18-20 months) and human brain samples showed a significant decline in sirtuin-1 expression (Sirt1; ~2.8-fold) confirmed at mRNA and protein levels and by activation assay. Experiments in Sirt1 transgenic mice and brain endothelial cell-specific Sirt1 knockout mice indicated that Sirt1 affects BBB integrity, with loss increasing permeability. Similarly, in vitro, overexpressing Sirt1 or increasing Sirt1 activity with an agonist (Sirt1720) protected against senescence-induced brain endothelial barrier hyperpermeability, stabilized claudin-5/ZO-1 interactions and rescued claudin-5 expression. These findings reveal a novel role of Sirt1 in modulating aging-associated BBB persistent leakage.

Indexed as

AgingAnimalsBlood-Brain BarrierCapillary PermeabilityEndothelial CellsHumansMiceSirtuin 1Sirtuin 1AgingBlood-brain barrierPermeabilitySirtuin-1Tight junction

Identifiers

PMID30196051
PMCPMC6401345
OpenAlexW2891781570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.